Advanced search×

Behavioural surveillance among gay men in Australia: methods, findings and policy implications for the prevention of HIV and other sexually transmissible infections.

Iryna B IB Zablotska, Susan S Kippax, Andrew A Grulich, Martin M Holt, and Garrett G Prestage

Sex Health 8(3):272-9 (2011) PMID 21851766

The Australian HIV and sexually transmissible infection (STI) behavioural surveillance system (the repeated cross-sectional Gay Community Periodic Surveys, GCPS) has been conducted since 1998 and covers six main Australian jurisdictions. In this paper, we review its history and methodology, and the available indicators, their trends and their use.

Version: za2963e q8za5 q8zbf q8zc5 q8zdd q8ze2 q8zf0 q8zg7

Similar articles you may find interesting…

  1. The incidence of acute urinary retention secondary to BPH is increasing among California men.
    H K Groves, D Chang, and J K Parsons

    Prostate Cancer Prostatic Dis (2013) PMID 23648398

    Between 2007 and 2010, the observed incidence of BPH-associated AUR increased substantially in a large and ethnically diverse male population of the United States.Prostate Cancer and Prostatic Disease advance online publication, 7 May 2013; doi:10.1038/pcan.2013.11....
  2. Novel Gene Expression Model for Outcome Prediction in Paediatric Medulloblastoma.
    Magdalena Zakrzewska, Sylwia M Grešner, and Pawel P Liberski

    J Mol Neurosci (2013) PMID 23649504

    We tried to analyse biomarkers for which a connection with the presence of stem/tumour-initiating cells was suggested. We evaluated the transcriptional level of the ATOH1, FUT4, NGFR, OTX1, OTX2, PROM1 and SOX1 genes in 48 samples of medulloblastoma and analysed their usefulness in the prediction of...
  3. Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.
    C E Olsson, N Pettersson, and G Steineck

    Br J Cancer (2013) PMID 23632483

    Survey participation rate was 89% (874/985) for eligible survivors and 73% (243/332) for eligible controls. Median time from treatment to follow-up was 5 years (range, 1-14 years). Among the 21 investigated symptoms reflecting obstruction, frequency, urgency, pain and incontinence, we found significa...